Islet Transplantation Using Campath-1H and Infliximab Induction

NCT00175266 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: alemtuzumab
PROCEDURE: islet transplant
DRUG: infliximab

Sponsor

University of Alberta

Collaborators

[object Object]